Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin and fluoxetine for mild COVID-19
IRCT20220827055798N1Phase 3Completed
- Sponsor
- Fasa University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ivermectin and fluoxetine in coronavirus disease 2019 (COVID-19), sponsored by Fasa University of Medical Sciences. Started Sep 2022; status: completed.
02
Drugs
ivermectinfluoxetine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20220827055798N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220827055798N1.